Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
AmyriAD Therapeutics B.V
Acquired Company
Recognify Life Sciences
Amsterdam
OregonBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CareDescription
AmyriAD Therapeutics has acquired Recognify Life Sciences and its lead clinical-stage program, RL-007. This acquisition strengthens AmyriAD's cognition pipeline, adding a differentiated treatment for cognitive impairment. Recognify shareholders will become shareholders of AmyriAD through this all-share transaction. AmyriAD aims to enhance cognitive function in CNS disorders using RL-007.
Fundz sees it the moment AmyriAD Therapeutics B.V makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Recognify Life Sciences?
Recognify Life Sciences was acquired by AmyriAD Therapeutics B.V, based in Amsterdam. The deal was reported on October 7, 2026. AmyriAD Therapeutics B.V. is a clinical-stage biopharmaceutical company focused on restoring cognitive function in CNS disorders. AmyriAD Therapeutics B.V is privately held and operates in Biotechnology.
When did AmyriAD Therapeutics B.V acquire Recognify Life Sciences?
AmyriAD Therapeutics B.V's acquisition of Recognify Life Sciences was reported on October 7, 2026. AmyriAD Therapeutics has acquired Recognify Life Sciences and its lead clinical-stage program, RL-007. This acquisition strengthens AmyriAD's cognition pipeline, adding a differentiated treatment for cognitive impairment. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Recognify Life Sciences do?
Recognify Life Sciences, Inc. is a biotech firm specializing in developing treatments for cognitive impairment. The company focuses on novel therapies to address cognitive dysfunction in various CNS disorders. It is privately held, operating in Biotechnology, and is based in Oregon.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.